CVE-2017-20017

The Next Generation of Genealogy Sitebuilding timeline2.php sql injection

Description

A vulnerability, which was classified as critical, has been found in The Next Generation of Genealogy Sitebuilding up to 11.1.0. This issue affects some unknown processing of the file /timeline2.php. The manipulation of the argument primaryID leads to sql injection. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 11.1.1 is able to address this issue. It is recommended to upgrade the affected component.

Category

6.3
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.06%
Third-Party Advisory vuldb.com
Affected: unspecified The Next Generation of Genealogy Sitebuilding
Published at:
Updated at:

References

Link Tags
https://vuldb.com/?id.105833 third party advisory

Frequently Asked Questions

What is the severity of CVE-2017-20017?
CVE-2017-20017 has been scored as a medium severity vulnerability.
How to fix CVE-2017-20017?
To fix CVE-2017-20017, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-20017 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2017-20017 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-20017?
CVE-2017-20017 affects unspecified The Next Generation of Genealogy Sitebuilding.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.